
Escalating treatment with an SGLT2 inhibitor
Explore treatment decisions surrounding SGLT2 inhibitors, including when they are recommended and how to select between them.
Explore treatment decisions surrounding SGLT2 inhibitors, including when they are recommended and how to select between them.
Guidelines from the ESC, published September 2019, include recommendations regarding first-line monotherapy that have proven divisive among the expert community. Hear from international experts on when and how to implement these recommendations in practice.
Consider combination therapy approaches in a patient with established renal failure and elevated cardiovascular risk